8-(2-aminoethyl)-5-hydroxy-4H-1,4-benzoxazin-3-one,hydrochloride

DRUG INTERMEDIATES

Product Details

CAT No.# CS-BJ-00077
Category Drug Intermediates
CAS 1035229-35-6
Molecular Weight 244.67
Molecular Formula C10H13ClN2O3
Synonyms: 8-(2-aminoethyl)-5-hydroxy-3,4-dihydro-2H-1,4- benzoxazin-3-one hydrochloride
Shipping: Free Shipping for worldwide on order above 2000 USD
COA / MSDS:    View COA    MSDS
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
8-(2-aminoethyl)-5-hydroxy-4H-1,4-benzoxazin-3-one,hydrochloride Worldwide Suppliers of 8-(2-aminoethyl)-5-hydroxy-4H-1,4-benzoxazin-3-one,hydrochloride Drug Intermediates Clearsynth CS-BJ-00077

Product rating: 9 8-(2-aminoethyl)-5-hydroxy-4H-1,4-benzoxazin-3-one,hydrochloride based on 20 ratings

  1. Drug Intermediates
  2. 8-(2-aminoethyl)-5-hydroxy-4H-1,4-benzoxazin-3-one,hydrochloride
PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. tibolone (848)
11. (Z)-Dimethylvinphos
12. Silodosin Metabolite
13. 2-Phenoxymethanesulfonanilide
14. Nimesulide EP Impurity A
15. Acetone HPLC
16. Nandrolone Decanoate EP impurity F
17. N-(4-Bromophenyl)-3-methyl-N-(m-tolyl)aniline
18. Thyroxamine
19. Ortho toluene sulfonic acid
20. Sucrose (1623637)




This page contains information about 8-(2-aminoethyl)-5-hydroxy-4H-1,4-benzoxazin-3-one,hydrochloride Cas 1035229-35-6 and its Drug Intermediates.

8-(2-aminoethyl)-5-hydroxy-4H-1,4-benzoxazin-3-one,hydrochloride 8-(2-aminoethyl)-5-hydroxy-4H-1,4-benzoxazin-3-one,hydrochloride Drug Intermediates of 8-(2-aminoethyl)-5-hydroxy-4H-1,4-benzoxazin-3-one,hydrochloride Drug Intermediates Clearsynth 1035229-35-6 https://www.clearsynth.com/en/temp/CS-BJ-00077.jpg

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."